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Establishing a Mental Health Surveillance in Germany:  
Development of a framework concept and indicator set
Abstract
In the course of the recognition of mental health as an essential component of population health, the Robert Koch 
Institute has begun developing a Mental Health Surveillance (MHS) system for Germany. MHS aims to continuously 
report data for relevant mental health indicators, thus creating a basis for evidence-based planning and evaluation of 
public health measures. In order to develop a set of indicators for the adult population, potential indicators were identified 
through a systematic literature review and selected in a consensus process by international and national experts and 
stakeholders. The final set comprises 60 indicators which, together, represent a multidimensional public health framework 
for mental health across four fields of action. For the fifth field of action ‘Mental health promotion and prevention’ 
indicators still need to be developed. The methodology piloted proved to be practicable. Strengths and limitations will 
be discussed regarding the search and definition of indicators, the scope of the indicator set as well as the participatory 
decision-making process. Next steps in setting up the MHS will be the operationalisation of the single indicators and 
their extension to also cover children and adolescents. Given assured data availability, the MHS will contribute to 
broadening our knowledge on population mental health, supporting a targeted promotion of mental health and reducing 
the disease burden in persons with mental disorders.
  PUBLIC HEALTH · SURVEILLANCE · MENTAL HEALTH · MENTAL DISORDERS · INDICATOR
1. Introduction
In recent years, the international public health agenda in the 
field of non-communicable diseases (NCDs) has undergone 
significant change. While the focus has long been on phys-
ical diseases such as cancer, diabetes, cardiovascular dis-
eases and chronic respiratory diseases, since 2018 the World 
Health Organization (WHO) has also attached the highest 
importance to mental disorders and well-being for popula-
tion health [1]. In 2015, the United Nations declared the 
promotion of mental health and well-being and the strength-
ening of approaches to prevent and treat substance abuse 
as explicit policy goals for sustainable development [2]. How-
ever, many countries still lack the necessary reporting sys-
tems for a robust data-based assessment of health develop-
ments in the comparatively emergent field of public mental 
health. Accordingly, the WHO Mental Health Action Plan 
(2013–2020, which has been extended until 2030) empha-
sises the need to establish national information systems for 
mental health indicators as one of its four objectives [3]. 
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Public Health is defined as ‘the art and science of pre-
venting disease, prolonging life and promoting health 
through the organized efforts of society‘ [4, as cited in 5]. 
Public Mental Health applies the concept of public health 
to mental health and disorders [6]. Surveillance in the field 
of public health refers to the ongoing and systematic col-
lection, collation, analysis, interpretation and timely dis-
semination of data on health and well-being and their deter-
minants [7]. Surveillance thus serves as a basis for planning, 
implementing and evaluating measures to protect and 
promote health in the population. The approach is centred 
around a defined set of meaningful and reliably measur-
able indicators (Info box 1). These are populated with data 
which is collected and reported continuously and can be 
compared over time to identify changes as well as specific 
needs for different population groups (stratified by age, 
gender, education, etc.). 
In contrast with physical non-communicable as well as 
infectious diseases, Mental Health Surveillance (MHS) as 
a continuous and indicator-based reporting of mental 
health poses specific challenges: (1) mental health is a 
broad concept and as such encompasses more than merely 
the absence of mental disorders [9]. The dual-factor model 
separates mental health into two interrelated, but distinct 
dimensions of positive mental health (well-being) and psy-
chopathology (symptoms and disorders) [10, 11]. In terms 
of their epidemiology, development, course and disease 
burden, the group of mental health conditions includes a 
highly diverse set of disorders. Moreover, despite suffering 
from psychopathology, people can experience their mental 
health as positive [11] because mental health describes ‘a 
state of wellbeing, in which an individual realizes his or her 
own abilities, can cope with the normal stresses of life, 
can work productively and is able to make a contribution 
to his or her community’ [12]. Such an approach to map-
ping mental health in its entirety therefore resembles the 
attempt to develop a set of indicators to describe ‘physi-
cal health’ (instead of ‘physical illnesses’). For physical 
NCDs, this is not yet commonly done, as there are usually 
separate surveillance subsystems for each respective dis-
ease and its risk factors that do not include salutogenetic 
(health-related) determinants and outcomes [13]. In addi-
tion, the interaction of risk and protective factors with men-
tal health and the outcomes of mental disorders is extremely 
complex [14]. For many topics, there are age- and culture- 
specific constructs. Accordingly, public health-oriented 
reviews of potential MHS indicators produce broad results 
[15, 16] with a respective requirement for selection and pri-
oritisation. (2) Unlike the laboratory parameters in the case 
of physical illnesses, the indicators for mental health are 
rarely directly observable or discretely measurable. Thus, a 
population-based, valid and reliable measurement of men-
tal health poses high demands on data collection [17, 18]. 
Many constructs lack a gold standard for their recording 
in health surveys. At the same time, partly due to advance-
ments in research, the classification of mental disorders 
changes , i.e. regarding their definition and the classifica-
tion of specific clinical pictures, their diagnostic criteria 
and threshold values [19]. This complicates the establish-
ment of standards for surveillance and can, in some cases, 
require a dynamic adjustment of disorder categories. Deter-
mining the prevalence of mental disorders in the popula-
tion requires in-depth and hence resource-intensive clinical 
interviews. In addition, different data sources (survey vs 
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monitoring systems focussed on the provision of care for 
people with mental disorders on the basis of routine data 
has been implemented or is currently being introduced by 
several countries [30, 31], meaning that these systems are 
currently more developed than monitoring with an epide-
miological or public health focus. Additionally to the afore-
mentioned differences in individual countries’ surveillance 
systems, different methods were used to develop and select 
indicators. For instance, either clearly operationalised mea-
sures [29, 32] or theoretical constructs without a definition 
of numerator and denominator [15, 24, 33] included as indi-
cators in the development process. Research and selection 
of indicators may be limited to those with available data 
[32, 34] or may also include constructs that can be captured 
in principle but for which no data are currently available 
[16, 23, 24, 33]. Key decisions in indicator system set-up 
can be made either by health monitoring professionals [29, 
34] or through the involvement of various stakeholders [16, 
24, 32, 33]. All methodologies have their specific advantages 
and disadvantages for the resulting surveillance system 
with regard to e.g. feasibility and acceptance as well as their 
capacity to deal with data gaps.
In addition to meeting a country’s information needs, 
an MHS system should ideally also serve the country’s 
international reporting obligations. These include, for 
example, the WHO Mental Health Atlas [35] regularly 
requests cross-national data to assess the achievement of 
the Mental Health Action Plan [3]. International compara-
bility is also the focus of the Organisation for Economic 
Co-operation and Development’s (OECD [36]) Mental 
Health Performance Benchmark, for which indicators and 
reporting formats are currently being developed. At EU 
routine data) may provide different estimates for one con-
struct and then require triangulation (i.e. a comparative 
discussion) [20]. (3) Furthermore, in the case of mental 
disorders, social stigma constitutes a special source of 
bias that influences data collection in self-report and 
observer rating and can also lead to misclassifications in 
health care settings [17].
Systems of Mental Health Surveillance developed to 
date have adopted different approaches to deal with these 
requirements. As the following international examples illus-
trate, they differ considerably in terms of content focus and 
degree of implementation. In some cases (e.g. Switzerland 
[21, 22] and Australia [23]), selected indicators of mental 
health are recorded and communicated in various report-
ing formats (health reports, interactive websites or dash-
boards, reports for the evaluation of political objectives, 
etc.) yet without explicitly setting up a systematic surveil-
lance system. In Canada, three independent subsystems 
within a comprehensive system of public health surveil-
lance regularly provide information on positive mental 
health (well-being) [24] and on suicidality [25], taking the 
respective risk and protective factors into account, as well 
as on mental disorders diagnosed in health care settings 
(Canadian Chronic Disease Indicators) [26]. In the US, a set 
of indicators focuses on mental disorder prevalence and 
care, with particular emphasis on substance abuse and this 
is currently being tested by several states [27]. The Scottish 
indicator set on well-being and mental health has only once 
reported results on indicators of positive mental health 
(well-being), psychopathology and their determinants [28] 
notwithstanding additional quality assurance indicators 
developed for the care sector [29]. Such systematic quality 
Info box 1  
What is an indicator?
An indicator is a precisely defined measure which is 
used to describe an underlying construct (indican-
dum) as comprehensively as possible. It consists of 
the ‘metadata’ (name of the indicator and definition 
for quantification, e.g. its numerator and denomina-
tor concept) as well as the data itself [8]. 
For comprehensive public health surveillance, indi-
cators should represent all relevant fields of action 
of public health measures (health promotion, pre-
vention, treatment and rehabilitation) as well as a 
dimensional spectrum of health and its determi-
nants.
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reports by individual health insurers [50–53] and other ser-
vice providers and support systems [54, 55], expert reports 
from various research institutions [56, 57] as well as results 
from the nationwide health monitoring at the Robert Koch 
Institute (RKI) [e.g. 58] and other population studies [59]. 
Indicators differ in terms of case definition, operationali-
sation, the underlying sample or reference population as 
well as survey design and mode. Incongruent observation 
periods and a lack of longitudinal studies make it particu-
larly difficult to assess trends and interactions of develop-
ments in morbidity and health care cannot be mapped 
validly. Another factor contributing to this situation is that, 
for most studies, only a few measurement points are avail-
able, e.g. to determine the prevalence of mental disorders 
in the general population by a standardised diagnostic 
interview for example (last recorded with the survey period 
2009–2012 [60]).
Furthermore, reporting concerning some aspects of pub-
lic mental health presents gaps that are owed as much to 
a lack of research and indicator development on individual 
topics, as to the lack of population-based data sources in 
various areas. 
Moreover, the data situation can be expected to improve 
for indicators on mental health quality of care. However, 
since a cross-sectoral and cross-disorder quality assurance 
procedure (QA procedure) could not be implemented [61] , 
even after the implementation of the indicator-based QA 
procedures currently being developed for schizophrenia, 
schizotypal and delusional disorders [62] and for outpa-
tient psychotherapy [63], information will only be available 
on diagnosis- or therapy-specific subgroups of patients. In 
addition, eight quality indicators on the provision of care 
level, after initial preliminary work to develop a cross-national 
indicator set on mental health [15, 16], only a few parame-
ters have been bindingly included in the 88 European 
Health Indicators to date, and databases have not yet been 
generated for most of them [37]. In principle, the realisa-
tion of international comparative reporting by a national 
MHS will also depend on the extent to which these indica-
tors are also meaningful at country level.
1.1 Public Mental Health reporting in Germany
A concise overview of central developments of public men-
tal health in Germany is only possible to a limited extent 
and contains gaps. Although large amounts of data on the 
mental health of the population are available from both 
studies and health care, the diversity of its contents, col-
lection purposes and data holders provides an overall frag-
mented data situation. Furthermore, health policy mea-
sures for the care and prevention of mental disorders in 
Germany are characterised by the country’s federal struc-
ture and the responsibility of numerous ministries and 
actors, in addition to which such measures are generally 
organised across several professional groups, sectors and 
cost bearers [38]. Thus, it is hard to provide findings on 
overaching developments. 
Consequently, reviews of the population’s mental health 
and mental disorders usually come with an array of indi-
cators and this heterogeneity thwarts a consistent sum-
mary interpretation and discussion [39–46]. The data 
sources included are multiple kinds of raw data in different 
reporting formats, such as psychiatry reports and studies 
conducted by the federal states [e.g. 47, 48, 49] focus 
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1.2 Setting up Mental Health Surveillance at the  
Robert Koch Institute
For a long time, in Germany too, the surveillance approach 
has been limited to infectious diseases and cancer. A con-
cept for NCD surveillance is currently being developed at 
the RKI and has already been successfully introduced for 
diabetes since 2016 [67]. Following this example, the Fed-
eral Ministry of Health commissioned the RKI to start devel-
oping a Mental Health Surveillance (MHS) for Germany in 
2019. The current pilot phase is focused on designing and 
testing the systematic development of a set of public men-
tal health indicators. This phase should yield findings on 
the current state of research as well as research needs for 
individual indicators and therefore lay the ground for their 
future integration into the planned NCD surveillance. The 
project is initially limited to parameters for the adult pop-
ulation. This article describes and discusses the systemat-
ic development of a set of indicators as part of the piloting 
of an MHS for Germany.
2. Methodology
In order to facilitate a later integration into a superordinate 
NCD surveillance based on uniform procedures, the con-
ception of the MHS indicator set used the tried and tested 
method of the Diabetes Surveillance at the Robert Koch 
Institute as a blueprint [67]. WHO’s recommendations for 
the establishment of a mental health information system 
were taken into account [68]. Figure 1 provides an overview 
of the steps in this process and is the reference for the 
ordinals (1) – (12) used below.
to people with unipolar depression are integrated in the 
Federal Joint Committee’s Disease Management Pro-
gramme (DMP) Depression [53]. Following implementa-
tion of the DMP in care across Germany a nationwide uni-
form recording of these indicators will become available. 
Consequently, a MHS should also provide indicators of 
quality of care, and these, depending on the development 
stage of QA procedures and DMP implementation, could 
also be included in the selection of indicators. 
It is worth noting that, from the point of view of quality 
monitoring, there is an explicit demand for its parameters 
to be evaluated in conjunction with epidemiological mea-
sures continuously being collected, as the public health 
impact can only be recognised in this way as an overall 
effect of the health care system on population health [31] 
and developments in care provision thus can be interpreted 
against the background of changing needs [64].
In summary, a consensus on key public mental health 
parameters and a systematic and continuous data provi-
sion still need to be established. Otherwise it is difficult to 
assess the extent to which health policy goals are being 
met and whether health care and public health measures 
are having an effective impact on population health. In 
2009, while evaluating the health goal depression, a clear 
but unmet need to generate and develop meaningful data 
sources [65] was recognised.This criticism that there was 
still no or only insufficient information available on key 
aspects was voiced again in 2018 [66]. 
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2.1 Involvement of international expertise and  
national stakeholders
Participation by experts and stakeholders (1)
For a surveillance system to effectively protect and promote 
public health, it must serve the specific information needs 
of citizens, decision-makers and researchers. Quality, a 
successful implementation also on the long-term, as well 
as acceptance and use of the system benefit from the par-
ticipation of relevant actors with their respective expertise 
and interests. For this reason, a diverse panel of public 
mental health stakeholders was invited to participate 
(Annex Table 1). 29 representatives of national stakehold-
ers from science, service providers, patient organisations, 
One key methodological decision needs to be pointed 
out in advance: The term indicator was limited to the 
indexed theoretical construct without a specific opera-
tionalisation for its quantification with defined numera-
tor and denominator [8]. Since each construct to be 
agreed upon contains various options for operationali-
sation depending on precise definition, measurement 
and data basis, this pragmatic simplification should facil-
itate the summarised presentation and comparative eval-
uation of the extraordinarily large number of potential 
indicators in the course of the selection process. In addi-
tion, the further process of setting up the MHS can ben-
efit from high flexibility when clarifying hitherto not spec-
ified data access. 
Figure 1
Process of development: 
Indicator set and framework concept
Source: Own figure
(2) Focus group: development 
of an initial framework concept 
by the mental health unit at the 
Robert Koch Institute






(3) Scoping Review of indicators on 
Public Mental Health
     181 indicators extracted (4) Workshop 1: ‘Integration of International Expertise 
in the Development of a Mental Health Surveillance 
System in Germany’ with international experts and 
national stakeholders(7) Indicator evaluation Delphi round 1 (online) 
by international experts und national stakeholders
(8) Review of the indicator pool and framework concept
     120 indicators refined
(5) Workshop 2: ‘Integration and long-term use of 
secondary data for Mental Health Surveillance in 
Germany’ with secondary data holders
(9) Indicator evaluation Delphi round 2 (online) by national 
stakeholders      57 indicators selected, one added
(6) Focus groups (online): ‘Mental disorders within the 
Mental Health Surveillance for Germany’ with national 
stakeholders
(10) Adoption of the final indicator set by national stakeholders (11) Evaluation of the consensus process by national 
stakeholders
(12) Expansion of the final indicator set by Federal Ministry 
of Health        2 indicators added
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Quantitative surveys (7, 9)
Two online surveys were conducted as part of the Delphi 
process (7, 9). The technical implementation was carried 
out based on the VOXCO software, the evaluation of the 
data was carried out using MS Excel 2019. The surveys 
were subject to data protection regulations under the Fed-
eral Data Protection Act and they were vetted and approved 
from a data protection perspective. 
2.2 Development of potential indicators and framework 
concept
Focus group to develop an initial framework concept (2)
A framework concept aims at the classification of indica-
tors according to content within an overarching, coherent, 
scientifically based model and can guide action [71]. To 
ensure compatibility with the preliminary work on NCD 
surveillance, the framework concept of Diabetes Surveil-
lance at the RKI was used as a starting point [67] and fur-
ther developed for the field of Public Mental Health by a 
focus group of researchers at the RKI’s Mental Health Unit 
(Department of Epidemiology and Health Monitoring). 
Scoping review to identify potential indicators (3) 
An extensive literature review of relevant public mental 
health indicators was conducted in the form of a scoping 
review [72, 73] to identify potential indicators for MHS. 
Over and above determining indicators which had already 
been established, the aim was also to identify new indica-
tors not yet established in reporting systems in terms of 
content or method ology. To gain an as complete picture 
as possible and to include various sources of information, 
federal and state politics as well as federal departmental 
research institutions took part. In order to strengthen inter-
national comparability and to learn from experiences made 
in other countries, experts from the WHO Mental Health 
Atlas and the OECD Mental Health Performance Bench-
mark as well as from two public health institutes with sys-
tematic mental health reporting (Swiss Health Observa-
tory, Public Health Agency Canada) could be won over for 
the project.
Workshops (4, 5) and focus groups (6)
A two-day workshop served as a kickoff to the process of 
opinion-forming by national stakeholders and the integra-
tion of international expertise in MHS development for 
Germany [69]. At a one-day workshop, representatives from 
various holders of routine data (Central Institute for Stat-
utory Health Insurance Physicians in Germany, German 
Institute for Medical Documentation and Information, Sci-
entific Institute of the AOK, Research Data Centre of the 
German Pension Insurance) as well as a representative of 
the Epidemiological Survey of Substance Abuse (Institute 
for Therapy Research) presented the potential the respec-
tive data bases have for quantifying public mental health 
indicators. The findings were incorporated into the descrip-
tion of potential indicators in Delphi round 2 (9).
Due to the COVID-19 pandemic, the third face-to-face 
workshop was changed to a set of four online focus groups 
[70]. Topics of discussion with national stakeholders included 
the methodologies for selecting those mental disorders with 
the highest public health relevance and the evaluation of 
their assessment in surveys and routine data. The discus-
sion results were used to refine Delphi Round 2 (9). 
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A comment field was used to request comments on the 
individual indicators (e.g. reasons for the assessment made, 
alternative operationalisations, notes on options to merge 
the indicator with other indicators or splitting of the indi-
cators into various sub-indicators).
To evaluate the survey, the indicators were then split 
into four groups based on the respondents’ assessment 
of their relevance [cf. 67]. 
  highly relevant: ≥75% of the ratings with 7 to 9 points
  relevant: ≥50%–74% of the ratings with 7 to 9 points
  medium relevant: ≥50% of the ratings with 1 to 6 points
  low relevant: ≥50% of the ratings with 1 to 3 points
The quantitative result of Delphi round 1 was fed back 
to the respondents.
Review of the framework concept and indicators (8)
Based on the qualitative feedback provided via the com-
ment fields in the survey, adjustments were made to the 
framework concept (renaming of fields of action and defi-
nition of topics) as well as to the indicators (mergers, dele-
tions and additions). Additional literature reviews were 
conducted on selected topics (e.g. mental health promo-
tion and prevention) and thematically focused discussions 
with additional experts were carried out. 
Indicator evaluation Delphi round 2 (online) (9)
During Delphi round 2, indicators were selected for given 
topics within each field of action to achieve a balanced indi-
cator set in terms of content [cf. 76]. It was determined, 
that each topic had to have at least two indicators assigned 
a systematic MEDLINE search via PubMed (limited to Ger-
man and English language publications) was supplement-
ed by additional searches on the websites of health care 
actors in Germany, public health institutes of all OECD 
(Organisation for Economic Co-operation and Develop-
ment) member states, as well as major international organ-
isations (WHO, OECD, EU). A detailed description of the 
research process can be found elsewhere [74].
2.3 Consensus on the final indicator set and framework 
concept 
Indicator evaluation Delphi round 1 (online) (7)
The panel of international experts and national stakeholders 
subsequently evaluated the identified indicators via a two-
stage Delphi process (Info box 2). Both Delphi rounds were 
conducted as online surveys. For Delphi round 1, the indi-
cators that were identified in the scoping review were illus-
trated through examples of their operationalisation based 
on the researched sources. Each indicator was individually 
assessed regarding its relevance based on a nine-point scale.
Relevance was defined in line with the criteria below [24] 
which have also been used in the development of other pub-
lic and mental health indicator systems [15, 23, 75, 76]: 
  Significant: the indicator has the potential to improve 
the protection and promotion of population mental 
health
  Actionable: the indicator provides information to update, 
influence or change policy and public health practice 
and can itself be influenced by policy and public health 
practice
Info box 2  
What is a Delphi process?
The Delphi method is an iterative process in which 
group opinions on an issue can be obtained through 
repeated questioning and feedback [77]. The agree-
ment (consensus) or disagreement (dissent) of 
opinions can be recorded and thus a voting result 
with the highest possible level of agreement sought. 
The procedure can be used in an anonymous for-
mat using a written survey and is widely established 
in the development of indicator systems [16, 24, 32, 
75, 76]. 
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Both highly relevant and relevant indicators were 
included in the final MHS indicator set. 
Adoption of the indicator set (10)
To capture stakeholders’ approval of the voting result of 
Delphi round 2 (Annex Table 2) as well as the resulting 
indicator set, both were sent to them by e-mail with the 
request to adopt or reject it as the final project result.
Evaluation of the consensus process (11)
To evaluate the consensus-finding process, national stake-
holders were asked for a standardised assessment as part 
of another anonymous online survey (regarding participa-
tion, agreement with the final project result, transparency 
of the procedure, workload, and personal willingness for 
further participation). 
Expansion of the final indicator set (12)
Public health surveillance must be orientated towards 
health policy information needs so it can fulfil its role in 
the governance of measures according to the definition of 
surveillance. The Federal Ministry of Health (German: 
Bundesminis terium für Gesundheit, BMG), as the com-
missioner and promoter of the development of MHS, did 
not participate in Delphi rounds 1 and 2, as the evaluation 
of indicators was to remain in the hands of national and 
international experts and stakeholders. The BMG reserved 
the right to review and, if necessary, expand (but not reduce) 
the approved set of indicators to add relevant indicators 
for health policy not reflected in the set agreed upon by the 
experts if necessary. In this way, the participation and posi-
tioning of the BMG could be communicated transparently.
to it in order for it to be adequately represented [cf. 76]. In 
addition, in order to reduce the number of indicators, a 
survey format was used that required respondents to pri-
oritise between indicators [cf. 24]. The respondents were 
asked to rank how aptly an indicator represented the respec-
tive topic compared to the others (Annex Table 2). Infor-
mation on (possible) operationalisations and data sources 
for indicators was provided.
To prioritise how compatible the final indicator set was 
with the information needs and data availability in Germany 
only the German stakeholders could take part in the online 
survey. The survey was divided into two parts in order to 
reduce the amount of time required for each survey. 
The aim of the evaluation, which was communicated in 
advance, was to reduce the number of indicators by at least 
50% in favour of a more manageable set [cf. 24] and to 
consider a measure of agreement among respondents [78]. 
Accordingly, two criteria were defined for assessing the rel-
evance of indicators:
  Ranking (cumulated): an indicator is relevant if it 
belongs to the indicators with a ranking above the 50% 
mark across all made assessments
  Consensus: an indicator is relevant if more than 50% 
of the respondents ranked it above the 50% mark
The indicators were classified according to these crite-
ria as follows:
  Highly relevant: both criteria (rank and consensus) met
  Relevant: only one of the criteria (rank or consensus) met
  Not relevant: neither of the criteria met
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(2) Reducing the risks of mental disorders: risk factors, 
psy chopathology, self-harm and suicidality; (3) Improving 
mental health care: supply and utilisation, needs, unmet 
needs and barriers, quality of care; (4) Reducing the bur-
den of disease and improving participation: costs, burden 
of disease, participation; (5) Strengthening knowledge 
and acceptance: mental health literacy. In addition, socio- 
demographic influencing characteristics were included 
as an individual field.
Scoping review to identify potential indicators (2) 
13,811 publications were identified using various research 
strategies. 373 of them were used to extract a total of 1,505 
relevant indicators. These were categorised accordingly, 
deduped and assessed for compatibility (how they adapt to 
the care structures in Germany, indicators for adult age, etc.). 
In total, 181 indicators of Public Mental Health could be iden-
tified, of which 47 (26%) were not included in any national 
and international indicator system. An additional eleven 
socio-demographic characteristics affecting mental health 
were not assigned to any field of action, but were included 
as potential stratification variables to identify particularly bur-
dened population groups in a MHS context. Details of data 
extraction and processing (overview of the identified indica-
tors) are presented elsewhere [74]. The number of indicators 
identified per topic and field of action was not equally distrib-
uted (Table 1), meaning that the topic area ‘mental health 
promotion and prevention’ was underrepresented compared 
to the topic area ‘supply and utilisation’ for example. Eight 
indicators were combined because their constructs over-
lapped; thus, Delphi round 1 started with 173 indicators and 
11 stratification characteristics.
In summary, the tasks were distributed as follows among 
the parties involved: the MHS working group at the RKI 
searched indicators (Scoping Review, 3) and, together with 
other mental health experts at the RKI, developed an initial 
system to structure them (initial framework, 2); invited 
international experts and national stakeholders to partici-
pate in the panel (1); organised and moderated a dialogue 
among experts in the form of workshops and focus groups 
(4, 5, 6); conducted three survey studies on indicator 
assessment (7, 9) and evaluation (11), evaluated these 
based on own methodology and reported results back to 
the participants; revised the indicator set and framework 
concept on the basis of the results (8) and obtained votes 
on the adoption of the indicator set (10) and its expansion 
(12). The experts and stakeholders involved consequently 
contributed their expertise at the joint events (4, 6), eval-
uated the indicators in the two Delphi surveys (7, 9), 
adopted the indicator set (10) and assessed the work pro-
cess during the course of the evaluation (11).
3. Results 
3.1 Development of potential indicators and  
framework concept
Development of an initial framework concept (2)
The focus group at the RKI identified 13 central topics in 
the field of public mental health and subsequently assigned 
them to five superordinate fields of action following the 
framework concept of the Diabetes Surveillance [67, 74]. 
They consisted of (1) Promoting mental well-being of the 
population: mental health promotion and prevention, men-
tal health resources, positive mental health (well-being); 
Increasingly, mental health  
is being recognised  
as a fundamental aspect  
of population health.
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Revision of the framework concept and indicators (8)
Based on the qualitative feedback from Delphi round 1 the 
framework concept was revised and additionally more close-
ly aligned with a multidimensional approach to mental 
health. For this purpose, mental health status was integrat-
ed into a ‘staging approach’ [14] with the two dimensions of 
positive mental health (well-being) and psychopathology 
[10]. This approach interprets psychopathology not as a cat-
egorical but as a dimensional construct, ranging from pre-
clinical symptoms up to manifest mental disorders in vary-
ing degrees of severity (called ‘stages’). The staging approach 
opens up several approaches to strengthening mental health 
at different levels (promotion: positive mental health, pre-
vention: mental distress, remission: mental disorders, recov-
ery: psychosocial impairment), each related to specific pub-
lic health measures (health promotion and prevention as 
well as treatment and rehabilitation). 
In order to reflect these conceptual decisions, fields of 
action were renamed, topics partially differentiated and 
redistributed (Figure 2): (1) ‘positive mental health’, ‘psy-
3.2 Consensus on the final indicator set and  
framework concept
Indicator evaluation Delphi round 1 (online) (7)
A total of 22 fully completed data sets were included in 
the evaluation (response rate: 91.7%). Of the 173 indica-
tors, 35.3% were assessed as highly relevant, 48.0% as 
relevant, 15.6% as medium relevant and 1.2% as low rele-
vant (Table 1). Of the stratification characteristics, 72.7% 
were assessed as highly relevant and 27.3% as relevant.
A majority of the indicators in fields of action 2 to 5 as 
well as the socio-demographic stratification characteristics 
were rated as highly relevant and relevant. Only in field of 
action 1 were the ratings across relevance classes more bal-
anced. As the survey format did not allow for a selection of 
indicators based on the quantitative results, the qualitative 
feedback (free comment fields for each indicator) was used 
to revise the indicator pool and the framework concept.
Table 1
Results of indicator evaluation according to 








Field of action 1: 
Promoting 
mental well- 
being of the 
population 









Field of action 4: 
Reducing the 
burden of disease 
and improving 
participation




Evaluation Number % Number % Number % Number % Number % Number % Number %
Highly relevant 61 35.3 1 3.1 17 33.3 21 38.9 15 62.5 7 58.3 8 72.7
Relevant 83 48.0 11 34.4 28 54.9 31 57.4 9 37.5 4 33.3 3 27.3
Medium relevant 27 15.6 18 56.3 6 11.8 2 3.7 0 0.0 1 8.3 0 0.0 
Low relevant 2 1.2 2 6.3 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Total 173 32   51   54   24   12   11  
There is a lack of  
systematically selected  
and continuously available 
data for mental health 
surveillance in Germany.
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The socio-demographic characteristics considered poten-
tial stratification variables were revised with the help of addi-
tional experts at the RKI. ‘Education’ was included as an 
indicator of social resources. ‘Unemployment’ and ‘poverty’ 
were classified as indicators of both social risk factors and 
consequences of disease. In order to homogenise future 
NCD surveillance, the stratification characteristics of age, 
gender, social situation, education and region (depending 
on the respective data availability) [67], on which consen-
sus was previously achieved in the context of Diabetes 
Surveillance, were adopted.
In the focus groups (6), criteria of public health rele-
vance were discussed with 18 representatives from national 
stakeholders, which could be used to select specific men-
tal disorders for the MHS in Delphi round 2, including, for 
example, their incidence, prevalence, disease burden, treat-
ability or also preventability, as well as methodological cri-
teria such as their epidemiological measurability in popu-
lation-based health studies (e.g. psychometric quality, 
sparseness of assessment). A proposal for the mental dis-
orders to be selected in Delphi round 2 (Annex Table 2) 
was accepted by the respondents and slightly modified by 
splitting the general category ‘stress disorders’ into ‘adjust-
ment disorders’ and ‘post-traumatic stress disorders’.
Indicator evaluation Delphi round 2 (online) (9)
In total, 80% (n=16) of the invited stakeholders participated 
in the first sub-survey, 65% (n=13) in the second sub-survey.
Based on the results, 57 of the 96 indicators from fields 
of action 2 to 5 were extracted for the final set of indicators 
(Annex Table 2). A total of 36 indicators were classified as 
highly relevant and 17 as relevant. Four indicators were 
chopathology’ and ‘self-harm and suicidality’ were included 
as characteristics of mental health status in the shared field 
of action 3 ‘Improving mental health status’. For the grad-
ual mapping of manifestations (staging approach) of men-
tal health problems, the topic of psychopathology was 
divided into the three topics (1) ‘preclinical symptomatol-
ogy’; (2) ‘mental disorders’; and (3) ‘comorbidities’. Field 
of action 5 ‘Reducing the burden of disease and strength-
ening participation’, which indicates the severity of mental 
impairments and its consequences, was supplemented by 
‘mortality’. (2) ‘Risk factors of mental disorders’ and ‘men-
tal health resources”, which had previously been assigned 
to two fields of action as they can influence both positive 
mental health (well-being) and psychopathology, were com-
bined into field of action 2 ‘Addressing determinants of 
mental health’ and supplemented by ‘mental health liter-
acy’ (formerly the separate field of action 5). (3) In order to 
reflect the spectrum of public health measures, field of 
action 1 ‘Improving mental health promotion and preven-
tion’ was added to complement the unchanged field of 
action 4 ‘Improving mental health care’. 
The additional in-depth and Germany-centric research 
into publications on mental health promotion and preven-
tion made it possible to add twelve further indicators to 
the indicator pool. However, as these only insufficiently 
represent the first field of action, they were placed outside 
the Delphi round 2 evaluation matrix and defined as an 
area for future development. A first assessment of the rel-
evance of these indicators in Delphi round 2 was con-
ducted to identify possible settings with high relevance 
for mental health promotion and prevention measures 
(Annex Table 2).
In order to set up a Mental 
Health Surveillance, the 
search, definition and  
selection of indicators for  
the broad spectrum of 
mental health was piloted.
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1. Help-seeking efficacy for 
mental health problems
2. Attitudes and stigma 
related to mental  
disorders
3. Knowledge about  
mental health and  
mental disorders
Positive mental health









3. Post-traumatic stress  
disorders (PTSD)
4. Psychotic disorders
5. Alcohol and substance 
dependence ***
6. Mental disorders (total)
Comorbidity
1. Comorbidity of mental 
disorders
2. Comorbidity with  










4. Contact-, meeting- and  
daycare-centres
5. Psychiatric home care
6. Specialist outpatient treatment
7. Rehabilitation **
8. Services outside the standard care  
of statutory health insurance
9. General practitioner treatment
10. Inpatient treatment
Quality




4. Psycho-/pharmacatherapeutic  
treatment rate




3. Access barriers to mental health care
4. Waiting times
Costs
1. Direct medical costs
Burden of disease
1. Sickness compensation *
2. Reduced earning  
capacity pension *
3. Experienced  
stigmatisation  
and discrimination *
4. Health-related quality  
of life *






1. Years of life lost (YLL) *
2. Suicides
3. Excess mortality *
Characteristics used for stratification of population based data analyses: age, sex, social status, education and region (depending on data availability)
*     due to/in mental disorders
**    Indicators were added to the indicator set to depict the realm of „Recovery“ within the framework, though both of the relevance criteria were not fulfilled
*** Indicator was added in consultation with the Federal Ministry of Health because of specific relevance for health politics
GKV = Statutory health insurance








The final set comprises  
60 indicators across  
four fields of action.
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to participate was fit for purpose, 11.6% would have become 
even more involved if necessary. All respondents would be 
willing to participate in the further development of MHS 
in the future.
4.  Discussion
Following international examples, the RKI has begun to devel-
op a MHS for Germany. The steps taken highlight the increas-
ingly recognised importance of mental health as an aspect 
of population health and responds to the high demand for 
an up-to-date and sustainable evidence base for the design 
of public mental health measures. The MHS aims for more 
comprehensive and reliable assessments of the mental health 
of the population by continuously providing data for an indi-
cator set on which consensus has been achieved. The pilot-
ing of a German MHS presented in this paper yielded the 
following results: a structured consensus process condensed 
the extensive pool of indicators identified by means of a sys-
tematic literature search to 60 indicators. These indicators 
represent a multidimensional framework for public mental 
health. A broad consensus for the selected set of indicators 
could be achieved among the involved stakeholders. In order 
to critically discuss the applied procedure, it will be reflected 
on the focus of the final indicator set and the strengths and 
limitations of methodological decisions and next steps to 
developing the surveillance system will be presented. 
Final indicator set
The final set of indicators is indicative of the different focus-
es of the stakeholders involved in terms of content. Field of 
included to ensure that, as per definition, each topic should 
be represented by at least two indicators. Despite its low 
ranking, the indicator ‘rehabilitation’ was subsequently 
included within the topic ,service provision and service use’ 
in order to also reflect the area of ‘recovery’ [79], which is 
anchored in the framework concept. 
Adoption of the indicator set (10)
The final indicator set was recognised and adopted by the 
majority of national stakeholders with an approval rate of 
85% (response rate: 95%, n=19). One abstention was jus-
tified due to the lack of opportunity for a detailed discus-
sion of individual indicators. One rejection was justified by 
the exclusion of the indicator ‘coercive measures’ as well 
as criticism of the indicator ‘psycho-pharmacotherapeutic 
treatment rate’.
Expansion of the indicator set (12)
In consultation with the Federal Ministry of Health, two key 
health policy indicators were added: ‘alcohol and substance 
dependence’ as a relevant group of mental disorders and 
‘coercive measures’ for the area of quality of care. The final 
set thus contains 60 indicators (Figure 2).
Evaluation of the consensus process (11)
Seventeen of the national stakeholders contributed to the 
evaluation of the consensus process (response rate: 85%) 
(Annex Table 3). The majority was satisfied with the oppor-
tunities to contribute their own opinion (88.2%), found 
their opinion adequately reflected in the outcomes (82.4%) 
and rated the procedure as sufficiently transparent (94.1%). 
In total, 88.2% of respondents felt that the effort required 
Corresponding indicators  
for the field of action ‘Mental 
health promotion and 
prevention’ remain  
to be developed.
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need for and access to care). Therefore, some indicators 
with special significance for the specific situation of people 
with chronic or severe mental disorders (e.g. physical health 
care and coercive measures) as well as indicators of per-
ceived treatment success and satisfaction from the patients’ 
point of view were not selected (although the coercive mea-
sures indicator was subsequently added, see above). 
In field of action 5 ‘Reducing the burden of disease and 
strengthening participation’, the direct determination of 
differentiated indicators regarding the individual and soci-
etal burden of disease was given preference over summary 
measures of the burden of disease model or the estimated 
economic costs. Poverty and unemployment were selected 
as indicators of participation, which is consistent with 
the prioritisation of social risk factors in field of action 2. 
To monitor mortality, overarching indicators of (excess) 
mortality were given preference over disorder-specific and 
care-associated measures.
Lessons learned
Compared to other internationally developed systems, the 
decision to create a public health-orientated framework 
has allowed the development of a comparatively compre-
hensive set of indicators. The framework covers both pos-
itive mental health (well-being) as well as a dimensional 
perspective of psychopathology; it therefore illustrates 
approaches for public health measures (health promotion, 
prevention, treatment and rehabilitation) at different levels. 
Thus, for the future integration of MHS into a superordi-
nate surveillance of non-communicable diseases, consent-
ed indicators for many issues are already available. These 
action 1 ‘Improving mental health promotion and preven-
tion’, highlights indicators on settings and measures repre-
senting the entire life span. In addition, information on anti- 
stigma and awareness campaigns was rated as relevant.
Field of action 2, ‘Addressing determinants of mental 
health’ looked at personal resources prioritising personality 
constructs such as optimism, resilience and self-esteem over 
competencies (communicative, social, and coping-related). 
Stressors (traumatisation and violence, chronic stress) and 
health behaviour were rated as central risk factors. Structural 
factors (poverty and unemployment) were prioritised along-
side loneliness as social risk factors. Correspondingly, com-
parable social resources (education and social support) were 
selected. For the topic of mental health literacy, which has 
to date hardly been studied at the population level, none of 
the three proposed indicators was prioritised. 
The special focus in field of action 3 ‘Improving mental 
health status’ was the prioritisation of mental disorders in 
the MHS. These disorders include depressive and anxiety 
disorders representing particularly common diagnostic 
groups and psychotic disorders as usually severe disorders 
in terms of course and consequences. In addition, post-trau-
matic stress disorders were selected, which is closely 
related to the high prioritisation of traumatisation and vio-
lence among the risk factors. 
In field of action 4 ‘Improving mental health care’, the 
entire spectrum of the care landscape received high ratings; 
community psychiatric services were also included as essen-
tial for surveillance. With regard to the issue of quality and 
patient-centred care, priority was given to indicators that 
address the entire group of persons with mental disorders 
requiring treatment (e.g. service use and treatment rates, 
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which reflect more recent developments in monitoring 
population mental health or that take specific concerns 
held in Germany into account. 
Restricting the indicator search and selection to con-
structs as opposed to precisely defined operationalisations 
at numerator and denominator level has also proven to be 
feasible in other such processes [24, 27, 28] and was indis-
pensable for the feasibility of the consensus-building pro-
cess. Only this pragmatic simplification has allowed those 
involved in the selection process to summarise and com-
pare the extraordinarily large number of potential indica-
tors. The development of clear and long-term metadata 
(title and definition) for the indicators, as well as the choice 
of their measurement and data basis, only takes place in 
a second step. This has the advantage, that the current and, 
as in the context of the COVID-19 pandemic, sometimes 
rapidly changing landscape of available data can be explored 
and included in detail. At the same time, research needs 
can be identified and the use of new inventories or survey 
methods tested. However, in the course of operationalisa-
tion, important decisions regarding content must be made 
and the methodological quality of the indicators needs to 
be ensured [8, 81].
The participatory development of an indicator set by a 
committee of experts and stakeholders is an established 
procedure [24, 32, 75], but not without alternatives [24, 27, 
28, 32, 75]. In this case, a broad acceptance of the result 
could be ensured, which, in turn, is a prerequisite for the 
effective use of the surveillance system. It must be recog-
nized, however, that any outcome of collective decision- 
making processes naturally always depends on the com-
position of the body involved. For example, differing inter-
also cover the association of mental and physical health 
in terms of common protective and risk factors, recipro-
cal influencing factors as well as co-morbidity and multi- 
morbidity. A comprehensive surveillance system focused 
on public health is more capable of reflecting the complex-
ity of health and disease than separate disease- or disor-
der-focused subsystems. However, this result was only 
achieved by following the approach taken by the Public 
Health Agency Canada [24, 76], namely a strict structuring 
of indicator selection in Delphi round 2 [24, 76] which had 
already anchored essential elements of the framework 
concept in the final indicator set. However, the procedure 
proved to be legitimate, as the stakeholders involved indi-
cated a high level of agreement with the final indicator set 
despite these specifications. 
Selecting indicators based on a systematic search of 
potential indicators has provided a set of indicators that 
also contains indicators for which no data suitable for sur-
veillance is available (yet). Unlike data-driven forms of indi-
cator selection [e.g. 27], the process has revealed urgent 
data needs and research gaps for core areas of public men-
tal health [cf. 23, 24, 80]. The majority of the indicators that 
were extracted during the extensive literature search came 
from indicator systems which were already established. In 
conclusion, a stronger orientation towards existing indica-
tor sets in combination with targeted follow-up research 
on underrepresented topics or special country needs can 
be recommended as efficient methods for developing a 
public mental health surveillance. At the same time, the 
approach we chose has allowed us to integrate constructs 
and topics (e.g. mental health literacy) not yet included in 
established surveillance systems into the structure of a MHS, 
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(1) Determining of the data basis available for each 
indicator: Currently and prospectively available popula-
tion-based data sources for the quantification of indica-
tors must be explored and evaluated. Concepts to close 
data gaps must be developed for those indicators that 
cannot be mapped at present. This includes both the not 
yet (routine) use of already available data sources as well 
as the development of new data sources from scratch. For 
indicators with a considerable need for development, a 
transitional use of interim indicators should be consid-
ered [cf. 23]. 
(2) Precise definition and operationalisation of indica-
tors: Survey formats or psychometric instruments must be 
selected, developed and tested for indicators for which data 
will need to be collected in surveys. To facilitate the use of 
MHS data as reference values for population norms, pref-
erence should be given to open access instruments. In 
addition, the use of mobile-based digital survey methods 
for estimating mental health indicators at overall popula-
tion level should be explored. For indicators based on rou-
tine data, appropriate definitions of cases or services to be 
considered need to be established and suitable data bod-
ies selected. Meanwhile, international comparability must 
be ensured by giving preference to internationally estab-
lished measures. At the same time, the operationalisation 
of indicators must allow for the greatest possible use of 
routine data and regular primary data collection beyond 
the RKI’s population studies. Only by doing so a continu-
ous surveillance for the large number of indicators of the 
MHS can realistically be feasible. If possible, the selected 
data sources should allow for the defined stratification. 
Due to the high significance of small-scale results for the 
ests on the committee can lead to the selection or dese-
lection of individual indicators. Although the aim was to 
win representatives of all relevant stakeholder groups, their 
respective representation (e.g. of mental health promotion 
and prevention actors versus service providers of outpa-
tient or inpatient care) can be viewed critically. In the case 
of the three indicators subsequently added (rehabilitation, 
coercive measures, alcohol and substance dependence), 
there is no consensus in the group involved. In the course 
of the advancement of the MHS in Germany, it seems 
important not to prioritise these three indicators in the fur-
ther scientific processing at the expense of those indicators 
that were determined by consensus.
Main criticisms from the experts and stakeholders 
involved were doubts about the significance of the ‘psycho- 
pharmacotherapeutic treatment rate’ indicator and the 
demand to include coercive measures. Due to overlaps in 
content and the difficulty of comparing constructs, the eval-
uation of indicators was considered difficult. The lack of 
indicators with reference to occupational health and work 
and for community psychiatric networking was criticised. 
In addition, the limited opportunities for an intensive dis-
cussion about individual indicators due to the restrictions 
imposed by the COVID-19 pandemic were deemed regret-
table but accepted.
Outlook
The development of an indicator set represents a first step 
in the establishment of a MHS in Germany. To establish a 
sustainable surveillance system for the selected topics, how-
ever, the following further work is necessary: 
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concept, a broad public mental health approach could be 
firmly established and existing gaps in indicator-based 
reporting in the field of mental health promotion and pre-
vention could be identified. The final set of indicators was 
selected on the basis of a differentiated assessment by the 
stakeholders involved. By this means, an essential contribu-
tion to the usefulness and acceptance of the system has 
been made with regard to the quality criteria of a surveillance 
system for mental health [17]. On this basis the development 
of the MHS in Germany can be continued. If the next steps 
are implemented according to plan, the MHS can become 
a helpful tool to make developments in public mental health 
in Germany visible in a timely manner, identify needs for 
interventions and burdened population groups and so con-
tribute to an evidence-based planning and evaluation of pub-
lic health measures aimed at promoting mental health and 
reducing the burden of disease of mental disorders.
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planning of measures the factor region plays a particularly 
important role.
(3) Encouraging continuous data availability: In order 
to provide close-meshed and continuous data, the regular 
collection of survey data and use of routine data must be 
ensured. International experience has shown [82] that this 
requires a constant influence on the planning of data col-
lections and evaluations in order to place the selected MHS 
indicators on their agenda. 
(4) Dissemination of results: In future, established and 
innovative formats of health reporting, such as those cur-
rently being tested for the Diabetes Surveillance [83], can 
be used for timely and appropriate MHS reporting. In order 
to promote their use by the addressees, suitable formats of 
direct exchange with the relevant actors must be developed. 
(5) Integration into NCD surveillance: A prudent selec-
tion of the MHS indicators identified here will be integrated 
into an overarching NCD surveillance. In the long term, a 
reporting system will be established, which depicts the rel-
evance of mental health for physical health [84], too. 
(6) Necessary extensions: Expansion potentials of the 
MHS indicator set proposed here lie a) in the addition of 
indicators for the age groups of children and adolescents 
as well as the elderly in order to map aspects of mental 
health across the lifespan, and b) in the elaboration of field 
of action 1 on the basis of the expected progress of preven-
tion reporting [85].
Conclusion
The piloted development of the present MHS indicator set 
has proven to be practicable overall. Through the framework 
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Annex Table 1 
Participating international experts 
and national stakeholders
Source: Own table
The listed persons participated in the development of the indicator set and framework concept 
(workshop 1, focus groups on the selection of mental disorders, Delphi round 1 or/and Delphi round 2).
Nr. Name Institution
1 Dr Marion Aichberger Department of Psychiatry and Psychotherapy at the Charité Campus Mitte, Charité –  
Universitätsmedizin Berlin
2 Prof Dr Harald Baumeister Department of Clinical Psychology and Psychotherapy, Institute of Psychology and Education,  
University of Ulm
3 Prof Dr Anke Bramesfeld Ministry for Social Affairs, Health and Equal Opportunities of Lower Saxony; Institute for  
Epidemiology, Social Medicine and Health System Research, Hannover Medical School (MHH)
4 Dr Daniel Hugh Chisholm World Health Organization, Regional Office for Europe
5 Jurand Daszkowski Federal Association of Psychiatry Experienced (BPE)
6 Prof Dr Freia de Bock Federal Centre for Health Education (BZgA)
7 Dr Julian Dilling National Association of Statutory Health Insurance Funds
8 Dr Theresa Eichhorn Federal Chamber of Psychotherapists in Germany (BPtK)
9 Prof Dr Wolfgang Gaebel WHO Collaborating Centre DEU-131; Rhineland Regional Council (LVR) – Klinikum Düsseldorf, 
Kliniken der Heinrich-Heine-Universität Düsseldorf
10 Prof Dr Dr Martin Härter University Medical Center Hamburg-Eppendorf, Center for Psychosocial Medicine,  
Department of Medical Psychology; German Network Health Services Research (DNVF)
11 Prof Dr Dr Andreas Heinz Department of Psychiatry and Psychotherapy at the Charité Campus Mitte, Charité –  
Universitätsmedizin Berlin
12 Emily Hewlett Organization for Economic Cooperation and Development (OECD)
13 Prof Dr Frank Jacobi Department of Clinical Psychology and Psychotherapy, Psychologische Hochschule Berlin
14 Dr Alessa Jansen Federal Chamber of Psychotherapists in Germany (BPtK)
15 Dr Joseph Kuhn Bavarian Health and Food Safety Authority (LGL)
16 Prof Dr Jutta Lindert University of Applied Sciences Emden/Leer; European Public Health Association,  
Section Public Mental Health
17 Prof Dr Jürgen Margraf Mental Health Research and Treatment Center, Ruhr-University Bochum
18 Alexandra Matzke German Depression League e.V.
19 Dr Hanne Melchior National Association of Statutory Health Insurance Physicians (KBV)
20 Prof Dr Andreas  
Meyer-Lindenberg
Central Institute of Mental Health, Medical Faculty Mannheim, Universität Heidelberg;  
German Association for Psychiatry, Psychotherapy and Psychosomatics e.V. (DGPPN)
21 Dr Dietrich Munz Federal Chamber of Psychotherapists in Germany (BPtK)
22 Dr Angelika Nebe Federation of German Pension Insurance Institutions (DRV Bund)
23 Dr Heather Orpana Public Health Agency Canada (PHAC)
24 Dr Judith Peth University Medical Center Hamburg-Eppendorf, Center for Psychosocial Medicine,  
Department of Medical Psychology
25 Prof Dr Ulrich Reininghaus Department of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, 
Universität Heidelberg
GKV = Statutory health insurance, WHO = World Health Organization Continued on next page
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26 Prof Dr Steffi Riedel-Heller Institute of Social Medicine, Occupational Health and Public Health (ISAP), Faculty of Medicine, 
University of Leipzig; German Association for Psychiatry, Psychotherapy and Psychosomatics e.V.
27 Dr Uwe Rose Federal Institute for Occupational Safety and Health (BAuA)
28 Dr Ursula von Rüden Federal Centre for Health Education (BZgA)
29 Prof Dr Georg Schomerus Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center (ULMC),  
Medical Faculty, University of Leipzig
30 Daniela Schuler Swiss Health Observatory (Obsan)
31 Prof Dr Martin Schütte Federal Institute for Occupational Safety and Health (BAuA)
32 Dr Thomas Stracke Federal Ministry of Health (BMG)
33 Thomas Voigt German Depression League e.V.
GKV = Statutory health insurance, WHO = World Health Organization
Notes to Annex Table 2:
Blue bold = highly relevant indicator (criteria rank AND consensus met), included in final indicator set
Black font = relevant indicator (criteria rank OR consensus met), included in final indicator set
Light grey font = not relevant indicator (no relevance criterion met), not included in the final indicator set
Blue background = indicator ranked in the top 50% of the indicators of a topic (odd number rounded down)
Grey shaded =  indicator that more than 50% of the respondents ranked in the top 50% of the indicators of a thematic field = number of ratings given by the  
participating stakeholders
1   Ranking (cumulative) = sum of the ranks of an indicator within a topic
2   Consensus = Percentage of participating stakeholders who placed the indicator in the top 50% of indicators for a topic (rounded down if odd number)
*     Indicator was included in the indicator set in order to depict the area of ‘recovery’ within the framework model, although neither of the two relevance criteria 
was met.
**    Indicator was subsequently included in the indicator set in consultation with the Federal Ministry of Health due to its relevance to health policy.
***   Indicator was included in the indicator set without voting because it was the only one representing the topic.
GKV = Statutory health insurance, ASHIP = National Association of Statutory Health Insurance Physicians, DALY = Disability-adjusted life years,  
YLD = Years lived with disability, YLL = Years of life lost, SHI = statutory health insurance
Annex Table 1 Continued 
Participating international experts 
and national stakeholders
Source: Own table
Annex Table 2 
Results of indicator assessment 
in Delphi Round 2




Field of action 1: Improving mental health promotion and prevention 
(under development; assessment outside Delphi process for initial assessment of the field of action)
Topic: Settings for possible indicators
Work environment/company 13 38 85%
Unemployment 13 43 62%
Kindergarten/daycare centre (KiTa) 13 44 77%
Family 13 59 46%
Nursing/care facility (senior citizens, people with disabilities) 13 66 54%
Municipality/community/district 13 67 38%
University/college/training company/vocational school 13 69 38%
School 13 82 0%
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Field of action 1: Improving mental health promotion and prevention 
(under development; assessment outside Delphi process for initial assessment of the field of action)
Topic: Indicators with currently available data
Anti-stigma and awareness raising 13 66 69%
SHI-supported measures in daycare centres for promotion and prevention in the field of mental health 13 71 77%
SHI-supported measures in schools for promotion and prevention in the field of mental health 13 74 77%
Relaxation or stress management offers by the employer 13 75 46%
Early help 13 82 62%
Health promotion measures at the workplace 13 85 38%
Stress management measures at the workplace 13 88 31%
Certified prevention services in the field of mental health 13 88 46%
Employer´s measures to prevent psychosocial risk factors in the workplace 13 92 31%
Risk assessment of mental health at the workplace 13 96 46%
Measures to deal with psychosocial risk factors at the workplace 13 98 46%
Measures to strengthen psychosocial health in care facilities 13 99 31%
Topic: Indicators for the self-report
Use 13 28 54%
Offer 13 29 69%
Demand 13 31 46%
Quality 13 42 31%
Field of action 2: Addressing determinants of mental health
Topic: Psychological resources
Optimism 16 44 75%
Resilience 16 46 69%
Self-worth 16 59 44%
Self-efficacy 16 63 44%
Coping skills 16 64 31%
Social/communicative competences 16 65 31%
Spirituality 16 107 6%
Topic: Social resources
Social support 16 37 56%
Education 16 38 63%
Life Domain Balance/work Life Balance 16 47 44%
Social and political participation 16 56 19%
Access to recreational and leisure opportunities 16 62 19%
Annex Table 2 Continued 
Results of indicator assessment 
in Delphi Round 2
Source: Own table
Continued on next page
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Field of action 2: Addressing determinants of mental health
Topic: Individual risks
Trauma/violence 16 42 69%
Chronic stress 16 55 50%
Unhealthy lifestyle 16 63 44%
Burden of chronic illness and/or chronic pain 16 64 44%
Experience of discrimination 16 67 31%
Stressful childhood experiences 16 69 38%
Exposure to family members with mental health problems 16 88 25%
Topic: Social risks
Loneliness 16 69 56%
Existential fears 16 70 56%
Unemployment 16 72 44%
Poverty/material deprivation 16 74 63%
Inequality in income or wealth distribution 16 78 56%
Homelessness 16 84 38%
Precarious housing conditions 16 87 38%
Stressful living environment 16 93 25%
Stressful working conditions 16 93 25%
Topic: Mental health literacy (Gesundheitskompetenz)
Help-seeking efficacy for mental health problems 13 24 77%
Attitudes and stigma related to mental disorders 13 26 69%
Knowledge about mental health and mental disorders 13 28 54%
Field of action 3: Improving mental health status
Topic: Positive mental health
Subjective mental health status 15 22 53%
Well-being 15 23 47%
Topic: Preclinical symptoms
Psychological distress 15 18 80%
Burnout symptoms 15 27 20%
Annex Table 2 Continued 
Results of indicator assessment 
in Delphi Round 2
Source: Own table
Continued on next page
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Field of action 3: Improving mental health status
Topic: Mental disorders
Depressive disorders 14 47 79%
Anxiety disorders 14 58 71%
Post-traumatic stress disorders (PTSD) 14 60 64%
Psychotic disorders 14 67 36%
Personality disorders 14 68 50%
Severe mental disorders 14 73 36%
Alcohol and substance dependence** 14 85 21%
Somatoform disorders 14 86 14%
Adjustment disorders 14 86 29%
Topic: Comorbidity
Comorbidity of mental disorders 14 20 57%
Comorbidity with chronic physical diseases 14 22 43%
Topic: Self-harm/suicidality
Self-harming behaviour 14 23 93%
Suicide attempts 14 25 79%
Suicidal thoughts and/or plans 14 36 29%
Field of action 4: Improving mental health care 
Topic: Supply and utilisation
Outpatient assisted living/ residential homes 13 53 77%
Self-help 13 75 46%
Online services (self-help, counselling, therapy) 13 77 54%
Contact-, meeting- and daycare-centres 13 79 54%
Psychiatric home care 13 79 54%
Specialist outpatient treatment 13 85 62%
Rehabilitation* 13 86 38%
Services outside the standard care of statutory health insurance 13 88 54%
General practitioner treatment (primary psychosomatic health care) 13 94 54%
Social psychiatric care 13 95 31%
Inpatient treatment 13 97 54%
Crisis services and counselling centres 13 106 23%
Annex Table 2 Continued 
Results of indicator assessment 
in Delphi Round 2
Source: Own table
Continued on next page
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Field of action 4: Improving mental health care
Topic: Quality
Physician/psychotherapist treatment rate  
(among patients with documented diagnosis of mental disorders)
13 50 77%
Utilisation rate (in population with mental disorders) 13 50 69%
Inpatient readmissions 13 51 62%
Psycho-/pharmacotherapeutic treatment rate  
(among patients with documented diagnosis of mental disorders)
13 53 62%
Treatment continuity after inpatient stay 13 59 46%
Psychiatric emergencies 13 66 38%
Somatic health care for people with mental disorders 13 78 31%
Quality target achievement in the Disease Management Programme (DMP) Depression 13 87 8%
Coercive measures** 13 91 8%
Topic: Patient-centering
Unmet need 13 37 54%
Treatment latency 13 41 54%
Access barriers to mental health care 13 46 46%
Waiting times 13 47 54%
Perceived treatment success (patient-reported outcome) 13 50 46%
Perceived patient orientation (patient-reported experience) 13 52 46%
Topic: Costs




Field of action 5: Reducing the burden of disease and strengthening participation
Topic: Burden of disease
Sickness compensation due to mental disorders 14 51 57%
Reduced earning capacity pension due to mental disorders 14 53 64%
Experienced stigmatisation and discrimination due to mental disorders 14 58 57%
Health-related quality of life in mental disorders 14 59 57%
Functional impairments due to mental health reasons 14 62 57%
Disability to work due to mental disorders 14 64 50%
Measures of the Burden of Disease Model for disease burden (DALY, YLD) 14 70 36%
Economic costs due to mental disorders 14 87 21%
Annex Table 2 Continued 
Results of indicator assessment 
in Delphi Round 2
Source: Own table
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Field of action 5: Reducing the burden of disease and strengthening participation
Topic: Participation
Poverty among people with mental disorders 14 33 57%
Unemployment among people with mental disorders 14 35 57%
Reintegration into labour market of people with mental disorders 14 39 50%
Social and political participation of people with mental disorders 14 47 21%
Homelessness of people with mental disorders 14 56 14%
Topic: Mortality
Measure of the Burden of Disease Model for mortality (YLL) 14 33 71%
Suicides 14 36 79%
Excess mortality of mental disorders 14 48 50%
Alcohol related deaths 14 56 36%
Drug related deaths 14 58 36%
Suicides during or after inpatient psychiatric treatment 14 63 29%
Annex Table 3 
Results of the evaluation 




„Rather disagree“ or 
„Disagree“
n % n %
1. I had sufficient opportunity to express my opinion in the 
course of the consensus process on the development of an 
indicator set.
15 88.2 2 11.8
2. I find my opinion sufficiently reflected in the results. 14 82.4 3 17.6
3. I found the procedure for selecting the core indicators suffi-
ciently transparent (e.g. regarding the steps of the consen-
sus process, evaluation criteria, documentation of results).
16 94.1 1 5.9






n % n % n %
4. How do you rate the effort required for your participation in 
the consensus process in relation to its purpose?
2 11.6 15 88.2 0 0
„yes“ „no“
n % n %
5. Would you be willing to participate in the development of 
the Mental Health Surveillance in the future?
17 100 0 0
n = Number of ratings given by the participating stakeholders, assessment of questions 1 to 3 on a four-point scale
Annex Table 2 Continued 
Results of indicator assessment 
in Delphi Round 2
Source: Own table
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